Copyright
        ©The Author(s) 2021.
    
    
        World J Gastrointest Oncol. Oct 15, 2021; 13(10): 1453-1465
Published online Oct 15, 2021. doi: 10.4251/wjgo.v13.i10.1453
Published online Oct 15, 2021. doi: 10.4251/wjgo.v13.i10.1453
		Figure 1 Prevalence of Helicobacter pylori infection in gastric marginal zone lymphoma.
		
			 MALT: Mucosa-associated lymphoid tissue.
		
	
		Figure 2 Gastric mucosa-associated lymphoid tissue lymphoma therapeutic algorithm.
		
			 HP: Helicobacter pylori.
		
	
		Figure 3 
              Example of dose distribution using volumetric modulated arc therapy in gastric mucosa-associated lymphoid tissue lymphoma.
		
			
            
		
	
- Citation: Quéro L, Labidi M, Bollet M, Bommier C, Guillerm S, Hennequin C, Thieblemont C. Radiotherapy for gastric mucosa-associated lymphoid tissue lymphoma. World J Gastrointest Oncol 2021; 13(10): 1453-1465
 - URL: https://www.wjgnet.com/1948-5204/full/v13/i10/1453.htm
 - DOI: https://dx.doi.org/10.4251/wjgo.v13.i10.1453
 
